Short answer · Medically reviewed summary · Last updated: 2026-04-06
Scheuermann’s disease was first formally described in 1920 by Danish surgeon Holger Werfel Scheuermann, who identified it as a distinct form of adolescent kyphosis characterized by wedging of the thoracic vertebrae. The Discovery and Early Understanding Before Dr. Scheuermann’s 1920 publication, medical literature often conflated spinal curvatures with Pott’s disease (tuberculosis of the spine) or simple "postural round back." Dr.
Scheuermann’s disease was first formally described in 1920 by Danish surgeon Holger Werfel Scheuermann, who identified it as a distinct form of adolescent kyphosis characterized by wedging of the thoracic vertebrae.
Before Dr. Scheuermann’s 1920 publication, medical literature often conflated spinal curvatures with Pott’s disease (tuberculosis of the spine) or simple "postural round back." Dr. Scheuermann utilized emerging X-ray technology to differentiate Scheuermann’s disease from other spinal deformities, noting the characteristic irregularities of the vertebral endplates and the herniation of disc material into the vertebral bodies, now known as Schmorl’s nodes. This shift allowed clinicians to stop misdiagnosing these patients with infectious diseases and recognize the condition as a developmental skeletal disorder.
Historically, management of Scheuermann’s disease was conservative, often involving prolonged bed rest or heavy plaster casts—methods that were later abandoned due to their negative impact on muscle strength and psychological well-being. As our understanding evolved, the focus transitioned toward physical therapy, bracing (such as the Milwaukee brace), and surgical intervention for severe cases. Over the decades, Scheuermann’s disease research has moved away from viewing it merely as a cosmetic issue, shifting toward a functional approach that addresses chronic pain management and long-term spinal health.
While the exact etiology remains multifactorial, modern imaging—including MRI and CT scans—has vastly improved our ability to diagnose Scheuermann’s disease early. Genetic research is ongoing, investigating the role of collagen and growth factors in the development of the vertebral endplates. Today, patient advocacy groups and platforms like DiseaseMaps provide a vital space for those living with Scheuermann’s disease to share experiences, move past historical misconceptions about posture, and access evidence-based support systems that were unavailable to previous generations.
Disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.